Sheba’s Innovalve Bio Medical LTD Acquired by Edwards Lifesciences Corporation
Innovalve, founded in 2017 at ARC Innovation, Sheba’s innovation arm, has developed an artificial mitral valve designed to be replaced using a minimally invasive catheter, addressing the needs of heart disease patients. The company has secured FDA approval for clinical studies and has successfully performed over 40 surgeries to date.
The creation of Innovalve was driven by the pioneering efforts of Prof. Ehud Raanani, Director of Sheba’s Cardiovascular and Thoracic Center, and Dr. Boris Orlev, Head of Sheba’s Mitral Valve Surgery Unit. Under the leadership of CEO Eyal Bar-Or, Innovalve has benefited from close collaboration with Sheba’s clinicians and developers.
This acquisition marks a significant step in the integration of cutting-edge technologies into Edwards’ transcatheter mitral and tricuspid therapies (TMTT) product group.
Prof. Yitshak Kreiss, Director General of Sheba Medical Center, commented on the acquisition:
“The health system is an engine of economic growth for the Israeli economy. Innovalve’s exit joins other Sheba companies acquired in recent months by international biomed giants, which have repeatedly expressed confidence in innovation coming out of Sheba. These achievements are made possible thanks to ARC – Sheba’s unique innovation platform, which encourages the development of groundbreaking technologies through the combination of technological entrepreneurship and extensive clinical knowledge and experience at the patient’s bedside. Soon we will see more and more deals of this kind, the fruits of which strengthen and develop the public health system. This is a real revolution that transforms the health system, which for years had to budget for the state, into a factor that generates significant revenues for the Israeli economy.”
More Posts
A Choice at 18, a Son at 44: How Sheba Restored Kassandra’s Fertility After 23 Years
At 18, before cancer treatment that could affect her fertility, Kassandra had portions of her ovarian tissue frozen, without knowing if medical science would ever advance enough to make parenthood possible for her. More than 23 years later, Prof. Dror Meirow, Director of the Fertility Preservation Center for Cancer Patients at Sheba Medical Center, and his team performed the transplant that eventually led to the birth of Kassandra’s son.
From Pilots to Clinical Practice: The Implementation of AI at Sheba
Sheba Medical Center is expanding the use of artificial intelligence across its departments, with AI systems already in active use in everyday clinical care. Sheba has also begun deploying a platform that gives clinicians access to medical literature and protocols at the point of care, while physicians remain responsible for medical decisions.
PinkStar & Mount Sinai Partnership to Advance Breast MRI Technology
A medical imaging startup first incubated within Sheba’s innovation ecosystem, PinkStar has entered an agreement with Mount Sinai Health System set to advance breast MRI protocols and support early cancer detection. The partnership marks PinkStar’s first collaboration with a U.S. academic medical institution.
